These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2393409)

  • 1. Serum oestradiol in women with and without breast disease.
    Bennett IC; McCaffrey JF; McCaffrey E; Wyatt B
    Br J Cancer; 1990 Jan; 61(1):142-6. PubMed ID: 2393409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk.
    Bruning PF; Bonfrèr JM; Hart AA
    Br J Cancer; 1985 Apr; 51(4):479-84. PubMed ID: 4038881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen binding and risk factors for breast cancer.
    Ingram DM; Nottage EM; Willcox DL; Roberts A
    Br J Cancer; 1990 Feb; 61(2):303-7. PubMed ID: 2310682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of oestradiol in plasma from postmenopausal women with or without breast cancer: relationships with metabolic clearance rates of oestradiol.
    Reed MJ; Beranek PA; Cheng RW; Ghilchik MW; James VH
    Int J Cancer; 1985 Apr; 35(4):457-60. PubMed ID: 4039300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of total and non-protein-bound oestradiol in patients with breast cancer and in normal controls.
    Moore JW; Clark GM; Bulbrook RD; Hayward JL; Murai JT; Hammond GL; Siiteri PK
    Int J Cancer; 1982 Jan; 29(1):17-21. PubMed ID: 7199515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum oestradiol-17 beta in women with benign and malignant breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Cancer; 1974 Dec; 30(6):571-6. PubMed ID: 4447785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum hormone levels in breast cancer patients and controls in Egypt and Great Britain. The Anglo-Egyptian Health Agreement Collaborative Study.
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1329-35. PubMed ID: 3181253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases.
    Langley MS; Hammond GL; Bardsley A; Sellwood RA; Anderson DC
    J Natl Cancer Inst; 1985 Nov; 75(5):823-9. PubMed ID: 3863985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormones in breast disease.
    England PC; Skinner LG; Cottrell KM; Sellwood RA
    Br J Surg; 1975 Oct; 62(10):806-9. PubMed ID: 1191940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls.
    Takatani O; Kosano H; Okumoto T; Akamatsu K; Tamakuma S; Hiraide H
    J Natl Cancer Inst; 1987 Dec; 79(6):1199-204. PubMed ID: 3480371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey.
    Thomas HV; Key TJ; Allen DS; Moore JW; Dowsett M; Fentiman IS; Wang DY
    Br J Cancer; 1997; 76(3):401-5. PubMed ID: 9252211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and endocrine aspects of transdermal 17 beta-oestradiol administration in post-menopausal women.
    Jasonni VM; Bulletti C; Naldi S; Ciotti P; Di Cosmo D; Lazzaretto R; Flamigni C
    Maturitas; 1988 Dec; 10(4):263-70. PubMed ID: 3226336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women.
    Takatani O; Okumoto T; Kosano H; Nishida M; Hiraide H; Tamakuma S
    Cancer Res; 1989 Jun; 49(11):3109-12. PubMed ID: 2720668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
    Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
    Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma sex steroids and SHBG in patients with breast cancer and their relation to tumor oestrogen-dependency.
    Teruel M; Bolufer P; Rodriguez A; Antonio P; Salabert MT
    Exp Clin Endocrinol; 1989 Apr; 93(1):37-44. PubMed ID: 2737240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone levels in older women: a study of post-menopausal breast cancer patients and healthy population controls.
    Bernstein L; Ross RK; Pike MC; Brown JB; Henderson BE
    Br J Cancer; 1990 Feb; 61(2):298-302. PubMed ID: 2138030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum oestradiol and breast cancer risk.
    Key TJ
    Endocr Relat Cancer; 1999 Jun; 6(2):175-80. PubMed ID: 10731106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
    Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
    Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical basis for the antagonism between aminoglutethimide and danazol in the endocrine treatment of breast cancer.
    Dowsett M; Murray RM; Pitt P; Jeffcoate SL
    Ann Clin Biochem; 1986 May; 23 ( Pt 3)():277-84. PubMed ID: 3789634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and breast disease. The role of the female sex hormones.
    Ingram D; Nottage E; Ng S; Sparrow L; Roberts A; Willcox D
    Cancer; 1989 Sep; 64(5):1049-53. PubMed ID: 2758382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.